Article
An experimental form of brachytherapy was highly efficacious and minimally toxic to healthy tissue in a mouse model of cancer, according to a recent study.
Intraprostatic drug elution therapy shows promise for BPH-related LUTS
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Combination therapy linked to longer OS vs ADT in veterans with mHSPC
Clarifying CPT 52353 billing for same-side stone cases
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test